Mutational status of nucleophosmin (npm1) and flt-3 genes are strong predictors of the outcome in patients with cytogenetic intermediate-risk acute myeloid leukemia undergoing autologous stem-cell transplantation

被引：0
|
作者：
Torrebadell, M.
Camos, M.
Brunet, S.
Rozman, M.
Pratcorona, M.
Nomdedeu, J.
Carrio, A.
Costa, D.
Colomer, D.
Carreras, E.
Camp, E.
Sierra, J.
Montserrat, E.
Esteve, J.
机构：
[1] Hosp Clin Barcelona, Barcelona, Spain
[2] Hosp Sant Pau, Barcelona, Spain
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0487
引用
收藏
页码：181 / 181
页数：1
相关论文
共 50 条
  • [1] Allogeneic Stem Cell Transplantation For Cytogenetically Normal Acute Myeloid Leukemia: Impact Of FLT3 and NPM1 Mutational Status
    Hemmati, Philipp
    Terwey, Theis H.
    Vuong, Lam G.
    le Coutre, Philipp D.
    Doerken, Bernd
    Arnold, Renate
    BLOOD, 2013, 122 (21)
  • [2] The Impact of Allogeneic Hematopoietic Stem-Cell Transplantation on Outcome of the Patients with Intermediate-Risk Acute Myeloid Leukemia
    Wang, Ying
    Wei, Hui
    Lin, Dong
    Zhou, Chunlin
    Liu, Bingcheng
    Qiu, Shaowei
    Gong, Benfa
    Zhang, Guangji
    Liu, Kaiqi
    Wei, Shuning
    Liu, Yuntao
    Gong, Xiaoyuan
    Zhao, Xingli
    Li, Yan
    Gu, Runxia
    Mi, Yingchang
    Wang, Jianxiang
    BLOOD, 2016, 128 (22)
  • [3] Impact of Allogeneic Stem Cell Transplant on Outcomes of Patients with Acute Myeloid Leukemia Based on NPM1 and FLT3 Mutational Status
    Meleveedu, Kapil Sankar
    Sidiqi, M. Hasib
    Nadiminti, Kalyan
    Hefazi, Mehrdad
    Alkhateeb, Hassan B.
    Shah, Mithun V.
    Phelps, Amy
    He, Rong
    Viswanatha, David S.
    Dingli, David
    Patnaik, Mrinal M.
    Hogan, William J.
    Litzow, Mark R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [4] FLT3 and NPM1 Are Powerful Determinants of Outcome in Acute Myeloid Leukemia Patients Treated with Autologous Stem Cell Transplantation: An Analysis By the Acute Leukemia Working Party of the EBMT
    Shouval, Roni
    Labopin, Myriam
    Bomze, David
    Baerlocher, Gabriela M.
    Foa, Robin
    Blaise, Didier
    Haenel, Mathias
    Forcade, Edouard
    Huynh, Anne
    Saccardi, Riccardo
    Milone, Giuseppe
    Zuckerman, Tsila
    Remenyi, Peter
    Esteve, Jordi
    Gorin, Norbert Claude
    Mohty, Mohamad
    Nagler, Arnon
    BLOOD, 2018, 132
  • [5] The prognostic impact of FLT3-ITD and NPM1 mutations in patients with relapsed acute myeloid leukemia and intermediate-risk cytogenetics
    J How
    J Sykes
    M D Minden
    V Gupta
    K W L Yee
    A D Schimmer
    A C Schuh
    S Kamel-Reid
    J M Brandwein
    Blood Cancer Journal, 2013, 3 : e116 - e116
  • [6] The prognostic impact of FLT3-ITD and NPM1 mutations in patients with relapsed acute myeloid leukemia and intermediate-risk cytogenetics
    How, J.
    Sykes, J.
    Minden, M. D.
    Gupta, V.
    Yee, K. W. L.
    Schimmer, A. D.
    Schuh, A. C.
    Kamel-Reid, S.
    Brandwein, J. M.
    BLOOD CANCER JOURNAL, 2013, 3 : e116 - e116
  • [7] The prognostic value of multilineage dysplasia in de novo acute myeloid leukemia patients with intermediate-risk cytogenetics is dependent on NPM1 mutational status
    Diaz-Beya, Marina
    Rozman, Maria
    Pratcorona, Marta
    Torrebadell, Montserrat
    Camos, Mireia
    Aguilar, Joseph L. I.
    Esteve, Jordi
    BLOOD, 2010, 116 (26) : 6147 - 6148
  • [8] Examination of the FLT3 and NPM1 mutational status in patients with acute myeloid leukemia from southeastern Poland
    Koczkodaj, Dorota
    Zmorzynski, Szymon
    Michalak-Wojnowska, Malgorzata
    Wasik-Szczepanek, Ewa
    Filip, Agata A.
    ARCHIVES OF MEDICAL SCIENCE, 2016, 12 (01) : 120 - 128
  • [9] The value of allogeneic stem cell transplantation in patients with intermediate risk (ELN) acute myeloid leukemia with no FLT3-ITD, no NPM1 mutations and no CEBPA double mutations
    Heidrich, K.
    Thiede, C.
    Schaefer-Eckart, K.
    Schmitz, N.
    Aulitzky, W. E.
    Kraemer, A.
    Roesler, W.
    Haenel, M.
    Einsele, H.
    Baldus, C. D.
    Trappe, R. U.
    Stoelzel, F.
    Middeke, J. M.
    Roellig, C.
    Taube, F.
    Kramer, M.
    Serve, H.
    Berdel, W. E.
    Ehninger, G.
    Bornhaeuser, M.
    Schetelig, J.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S81 - S81
  • [10] ANALYSIS OF THE FLT3-ITO AND NPM1 MUTATIONS IN AML PATIENTS WITH INTERMEDIATE RISK RECEIVING ALLOGENEIC STEM-CELL TRANSPLANTATION
    Ogasawara, M.
    Yamakawa, T.
    Katsura, Y.
    Shima, K.
    Matsukawa, T.
    Kanaya, M.
    Minauchi, K.
    Nakata, M.
    Ota, S.
    Imai, K.
    Hirano, T.
    Kobayashi, N.
    Kiyama, Y.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S297 - S297
12345